ESC Premium Access

About the speakers

Professor Christopher Paul Cannon

Cardiovascular Division, Brigham and Women?s Hospital, Harvard Medical School, Boston (United States of America)
30 presentations
0 follower

Professor Alberico Catapano

University of Milan - Department of Pharmacological Sciences and Bio, Milan (Italy)
34 presentations
3 followers

Professor Stephen Nicholls

Monash Heart, Melbourne (Australia)
34 presentations
1 follower

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)
25 presentations
2 followers

Doctor Jennifer Robinson

University of Iowa, Iowa (United States of America)
12 presentations
0 follower

6 more presentations in this session

Introduction - PSCK9 inhibition: a new horizon in LDL-C management.

Speaker: Professor C. Cannon (Boston, US)

Thumbnail

LDL-C exposure and atherosclerosis progression.

Speaker: Professor A. Catapano (Milan, IT)

Thumbnail

PCSK9 inhibition: the data today and tomorrow.

Speaker: Professor S. Nicholls (Melbourne, AU)

Thumbnail

Learnings and clinical insights from SPIRE.

Speaker: Doctor P. Ridker (Boston, US)

Thumbnail

Guidelines: commonalities and discrepancies.

Speaker: Doctor J. Robinson (Iowa, US)

Thumbnail

Access the full session

PSCK9 inhibition: a new horizon in LDL-C management

Speakers: Professor C. Cannon, Professor A. Catapano, Professor S. Nicholls, Doctor P. Ridker, Doctor J. Robinson...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk